A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis. (2021)
Attributed to:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41431-021-00900-2
PubMed Identifier: 34075211
Publication URI: http://europepmc.org/abstract/MED/34075211
Type: Journal Article/Review
Volume: 29
Parent Publication: European journal of human genetics : EJHG
Issue: 9
ISSN: 1018-4813